
Agios Pharmaceuticals Inc (0HB0)
LSE
Year End December 30 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 614.4M | 858.46M | 890.74M | 852.95M | 1.44B | 1.24B | 937.12M | 1.66B |
Total Current Assets | 445.26M | 613.78M | 611.7M | 636.68M | 1.06B | 832.77M | 833.84M | 965.6M |
Cash and Equivalents | 102.72M | 70.5M | 80.93M | 127.44M | 203.13M | 139.26M | 88.21M | 76.25M |
Total Non-Current Assets | 375.5M | 687.54M | 640.53M | 399.5M | 1.29B | 1.1B | 811.02M | 1.54B |
Total Liabilities | 238.89M | 170.92M | 250.21M | 453.45M | 145.76M | 137.9M | 126.1M | 122.24M |
Total Current Liabilities | 94.94M | 93.5M | 92.89M | 94.39M | 59.83M | 62.63M | 67.96M | 81.16M |
Total Non-Current Liabilities | 143.95M | 77.42M | 158M | 359.39M | 86.21M | 75.28M | 58.14M | 41.09M |
Total Equity | 375.5M | 687.54M | 640.53M | 399.5M | 1.29B | 1.1B | 811.02M | 1.54B |
Common Equity | 49k | 58k | 68k | 69k | 71k | 71k | 72k | 73k |
Retained Earnings | -798.06M | -1.1B | -1.52B | -1.84B | -238.76M | -470.56M | -822.65M | -148.92M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.